Eaton Vance Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $1.92M | Sell |
|
|||||
|
2022
Q2 | $3.55M | Sell |
|
|||||
|
2022
Q1 | $3.81M | Buy |
|
|||||
|
2021
Q4 | $3.83M | Buy |
|
|||||
|
2021
Q3 | $3.06M | Sell |
|
|||||
|
2021
Q2 | $3.54M | Buy |
|
|||||
|
2021
Q1 | $3.1M | Sell |
|
|||||
|
2020
Q4 | $3.58M | Sell |
|
|||||
|
2020
Q3 | $37.3M | Sell |
|
|||||
|
2020
Q2 | $41.5M | Sell |
|
|||||
|
2020
Q1 | $53M | Sell |
|
|||||
|
2019
Q4 | $87.2M | Sell |
|
|||||
|
2019
Q3 | $83.3M | Sell |
|
|||||
|
2019
Q2 | $90.1M | Buy |
|
|||||
|
2019
Q1 | $87.3M | Buy |
|
|||||
|
2018
Q4 | $74.4M | Buy |
|
|||||
|
2018
Q3 | $77M | Buy |
|
|||||
|
2018
Q2 | $51.7M | Buy |
|
|||||
|
2018
Q1 | $5.85M | Buy |
|
|||||
|
2017
Q4 | $2.64M | Sell |
|
|||||
|
2017
Q3 | $3.03M | Buy |
|
|||||
|
2017
Q2 | $2.87M | Sell |
|
|||||
|
2017
Q1 | $7.45M | Sell |
|
|||||
|
2016
Q4 | $11.3M | Buy |
|
|||||
|
2016
Q3 | $12.7M | Buy |
|
|||||
|
2016
Q2 | $12.7M | Buy |
|
|||||
|
2016
Q1 | $2.58M | Buy |
|
|||||
|
2015
Q4 | $2.56M | Sell |
|
|||||
|
2015
Q3 | $5.22M | Sell |
|
|||||
|
2015
Q2 | $7.19M | Buy |
|
|||||
|
2015
Q1 | $7.49M | Sell |
|
|||||
|
2014
Q4 | $6.94M | Sell |
|
|||||
|
2014
Q3 | $9.97M | Sell |
|
|||||
|
2014
Q2 | $11.6M | Sell |
|
|||||
|
2014
Q1 | $11.6M | Sell |
|
|||||
|
2013
Q4 | $12.9M | Sell |
|
|||||
|
2013
Q3 | $24.7M | Sell |
|
|||||
|
2013
Q2 | $24.9M | Buy |
|